Home > NRC Library > ADAMS Public Documents

06-19183-01 611001 Boehringer Ingelheim Pharmaceuticals, Inc.

Accession Number: ML19014A025

Date Released: Monday, February 25, 2019

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML19032A132 - Boehringer Ingelheim Pharmaceuticals, Inc.; Deficiency Response E-Mails dtd 01/17/19. (1 page(s), 1/17/2019)
• ML19044A519 - Boehringer Ingelheim Pharmaceuticals, Inc.; Deficiency Response Letter dtd January 16, 2019; Control No. 611001. (1 page(s), 1/16/2019)
• ML19045A605 - Boehringer Ingelheim Pharmaceuticals, Inc.; Cover Letter dtd February 4, 2019, for License Amendment No. 27; Control No. 611001. (3 page(s), 2/4/2019)
• ML19045A607 - Boehringer Ingelheim Pharmaceuticals, Inc.; License Amendment No. 27; Control No. 611001. (6 page(s), 2/4/2019)